Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001214659-25-002167
Filing Date
2025-02-06
Accepted
2025-02-06 21:16:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 7272
  Complete submission text file 0001214659-25-002167.txt   9224
Mailing Address 223 N. MATHILDA AVE. SUNNYVALE CA 94086
Business Address 223 N. MATHILDA AVE. SUNNYVALE CA 94086 (650) 938-6300
23andMe Holding Co. (Subject) CIK: 0001804591 (see all company filings)

EIN.: 871240344 | Fiscal Year End: 0331
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91734 | Film No.: 25599013
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 65 CHULIA STREET #45-04 OCBC CENTRE SINGAPORE U0 049513
Business Address 65 CHULIA STREET #45-04 OCBC CENTRE SINGAPORE U0 049513 6566351950
Zentree Investments Ltd (Filed by) CIK: 0001946012 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 0331
Type: SCHEDULE 13G/A